Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$70,833.00

Vascularization of Cerebral Organoids for Patient-Specific Neurodegenerative Disease Models

FY 2015-16

Summary
Because the human brain is so complex, it impossible to create animal models that truly mimic the onset of Alzheimer's disease and other neurodegenerative diseases. Ideally, we should use models based on each patient's genome to determine disease mechanisms. The 2014 Nobel Prize in Physiology or Medicine was awarded to Shinya Yamanaka for his work demonstrating that a skin cell can be "reprogrammed" into stem cells and re-educated into different cell types. Building on this work, several studies have shown that stem cells can be coaxed into forming little three dimensional clusters. Biological signals can make these clusters develop into miniature 1-4 mm tissues called "organoids" that can mimic features of the kidney, intestines or the cerebral cortex. These organoids bring forth a new era of personalized medicine where organ disorders can be studied for individual patients. Organoids are especially important for studying brain disorders since many have no pre-clinical models to guide drug development. Unfortunately, the major problem with organoids is that they lack a vasculature system. Once they grow too large it becomes difficult for oxygen and nutrients to reach the deeper cell layers. The lack of vasculature causes cell death, limits the development of the organoids, and affects cell function. To improve the culture of cerebral cortex organoids, we will fabricate clear gels that contain a network of 3D-printed synthetic blood vessels to ensure the even distribution of oxygen and nutrients. Small cerebral organoids will be placed in the gels for several weeks and as they grow they will integrate the synthetic blood vessels. These vessels will help feed cells, but can also be used to administer drugs and other stimuli so we can monitor neural responses. We will use vascularized organoids to study how Alzheimer's disease and Rett Syndrome affect brain architecture and neural response to facilitate long-term drug discovery strategies.
Program
CIHR Fellowship
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
338886
Name
Albanese Alexandre
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Vascularization of Cerebral Organoids for Patient-Specific Neurodegenerative Disease Models
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$70,833
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Brain Research; Cell Function; Neurodegenerative Disorders; Neurology; Syntetic Vasculature; Tissue Engineering
Abstract
Because the human brain is so complex, it impossible to create animal models that truly mimic the onset of Alzheimer's disease and other neurodegenerative diseases. Ideally, we should use models based on each patient's genome to determine disease mechanisms. The 2014 Nobel Prize in Physiology or Medicine was awarded to Shinya Yamanaka for his work demonstrating that a skin cell can be "reprogrammed" into stem cells and re-educated into different cell types. Building on this work, several studies have shown that stem cells can be coaxed into forming little three dimensional clusters. Biological signals can make these clusters develop into miniature 1-4 mm tissues called "organoids" that can mimic features of the kidney, intestines or the cerebral cortex. These organoids bring forth a new era of personalized medicine where organ disorders can be studied for individual patients. Organoids are especially important for studying brain disorders since many have no pre-clinical models to guide drug development. Unfortunately, the major problem with organoids is that they lack a vasculature system. Once they grow too large it becomes difficult for oxygen and nutrients to reach the deeper cell layers. The lack of vasculature causes cell death, limits the development of the organoids, and affects cell function. To improve the culture of cerebral cortex organoids, we will fabricate clear gels that contain a network of 3D-printed synthetic blood vessels to ensure the even distribution of oxygen and nutrients. Small cerebral organoids will be placed in the gels for several weeks and as they grow they will integrate the synthetic blood vessels. These vessels will help feed cells, but can also be used to administer drugs and other stimuli so we can monitor neural responses. We will use vascularized organoids to study how Alzheimer's disease and Rett Syndrome affect brain architecture and neural response to facilitate long-term drug discovery strategies.
Competitiondate
201511
Approvedterm2
1 yr 5 mths
Pinamesdelim
Albanese, Alexandre
Approvedterm
1 an 5 mois
Cihrcontribution2
~ $70,833~ $0~
Direct Payment - $70,833 Grant (2015-16) | Canada Spends